Microbiota and irritable bowel syndrome

The gut microbiota is involved in the pathophysiology of irritable bowel syndrome (IBS). A relevant therapeutic approach to IBS may involve modulation of this microbiota, particularly with the aim of controlling the intestinal hyper-permeability and frequent visceral hypersensitivity associated with this condition. (C) 2021 Published by Elsevier Masson SAS

Automated summary

The gut microbiota plays a crucial role in the pathophysiology of irritable bowel syndrome (IBS). Therapeutic approaches for IBS may involve modulating the microbiota to control intestinal hyper-permeability and frequent visceral hypersensitivity associated with this condition.